リバーロキサバンの世界市場2020-2026:2.5 mg、10 mg、15 mg、20 mg

QYResearchが発行した調査報告書(QYR20AP02070)
◆英語タイトル:Global Rivaroxaban Industry Research Report, Growth Trends and Competitive Analysis 2020-2026
◆商品コード:QYR20AP02070
◆発行会社(リサーチ会社):QYResearch
◆発行日:2020年3月
◆ページ数:117
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥563,500見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD7,350 ⇒換算¥845,250見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD9,800 ⇒換算¥1,127,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

当リサーチレポートでは、リバーロキサバンの世界市場規模が2019年xx百万ドルから2026年xx百万ドルまで年平均xx%成長すると予測しています。当レポートは、リバーロキサバンのグローバル市場動向、メーカー別競争状況、種類別市場規模(2.5 mg、10 mg、15 mg、20 mg)、用途別市場規模(急性冠症候群(ACS)、静脈血栓塞栓症(VTE))、北米市場、アジア市場、中南米市場、中東・アフリカ市場分析、関連企業情報、サプライチェーン、販売チャネル分析、地域別市場規模予測データなどを掲載しています。

・レポート概要
・グローバル市場動向
・メーカー別競争状況
・リバーロキサバンの種類別市場2015-2026:2.5 mg、10 mg、15 mg、20 mg
・リバーロキサバンの用途別市場2015-2026:急性冠症候群(ACS)、静脈血栓塞栓症(VTE)
・リバーロキサバンの北米市場分析
・リバーロキサバンのアジア市場分析
・リバーロキサバンの中南米市場分析
・リバーロキサバンの中東・アフリカ市場分析
・関連企業情報:Bayer、J&J
・サプライチェーン及び販売チャネル分析
・地域別市場規模予測2021-2026:北米、ヨーロッパ、アジア、中南米、中東・アフリカ
・結論
【レポートの概要】

Rivaroxaban is an oral anticoagulant invented and manufactured by Bayer; in a number of countries it is marketed as Xarelto. In the United States, it is marketed by Janssen Pharmaceutica. It is the first available orally active direct factor Xa inhibitor. Rivaroxaban is well absorbed from the gut and maximum inhibition of factor Xa occurs four hours after a dose. The effects last approximately 8–12 hours, but factor Xa activity does not return to normal within 24 hours so once-daily dosing is possible.The global average price of Rivaroxaban is in the decreasing trend, from 5.62 USD/Unit in 2011 to 5.34 USD/Unit in 2015. With the situation of global economy, prices will be in slowly decreasing trend in the following five years.
In 2019, the global Rivaroxaban market size was US$ 6908.7 million and is forecast to US$ 12070 million in 2026, growing at a CAGR of 8.2% from 2020. In this study, 2019 has been considered as the base year and 2020 to 2026 as the forecast period to estimate the market size for Rivaroxaban.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Rivaroxaban market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Rivaroxaban market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Rivaroxaban market. Readers of the report can become informed about current and future trends of the global Rivaroxaban market and how they will impact market growth during the forecast period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise and country-wise Rivaroxaban markets such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E etc.
For the period 2015-2026, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Rivaroxaban market. For the period 2015-2020, it provides sales (consumption) analysis and forecast of different regional markets by Application as well as by Type in terms of volume.
Market Segmentation by Type and by Application
The report includes a detailed analysis of leading and by Type and by Application segments of the global Rivaroxaban market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue, sales analysis and forecast of the global Rivaroxaban market by Type and by Application segment for the period 2015-2026.

Market Segment by Type, the Rivaroxaban market is segmented into
2.5 mg
10 mg
15 mg
20 mg

Market Segment by Application, the Rivaroxaban market is segmented into
Acute Coronary Syndrome (ACS)
Venous Thromboembolism (VTE)

This report includes the following manufacturers; we can also add the other companies as you want.
Bayer
J&J

The study objectives are:
To analyze and research the global Rivaroxaban status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Rivaroxaban manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Rivaroxaban are as follows:
History Year: 2015-2020
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Top Rivaroxaban Manufacturers Covered: Ranking by Revenue
1.3 Market Segment by Type
1.3.1 Global Rivaroxaban Market Size by Type: 2015 VS 2020 VS 2026 (US$ Million)
1.3.2 2.5 mg
1.3.3 10 mg
1.3.4 15 mg
1.3.5 20 mg
1.4 Market Segment by Application
1.4.1 Global Rivaroxaban Consumption by Application: 2015 VS 2020 VS 2026
1.4.2 Acute Coronary Syndrome (ACS)
1.4.3 Venous Thromboembolism (VTE)
1.5 Study Objectives
1.6 Years Considered
2 Global Market Perspective
2.1 Global Rivaroxaban Revenue (2015-2026)
2.1.1 Global Rivaroxaban Revenue (2015-2026)
2.1.2 Global Rivaroxaban Sales (2015-2026)
2.2 Rivaroxaban Market Size across Key Geographies Worldwide: 2015 VS 2020 VS 2026
2.2.1 Global Rivaroxaban Sales by Regions (2015-2020)
2.2.2 Global Rivaroxaban Revenue by Regions (2015-2020)
2.3 Global Top Rivaroxaban Regions (Countries) Ranking by Market Size
2.4 Rivaroxaban Industry Trends
2.4.1 Rivaroxaban Market Top Trends
2.4.2 Market Drivers
2.4.3 Rivaroxaban Market Challenges
2.4.4 Porter’s Five Forces Analysis
2.4.5 Primary Interviews with Key Rivaroxaban Players: Views for Future

3 Competitive Landscape by Manufacturers
3.1 Global Top Rivaroxaban Manufacturers by Sales (2015-2020)
3.1.1 Global Rivaroxaban Sales by Manufacturers (2015-2020)
3.1.2 Global Rivaroxaban Sales Market Share by Manufacturers (2015-2020)
3.1.3 Global 5 and 10 Largest Manufacturers by Rivaroxaban Sales in 2019
3.2 Global Top Manufacturers Rivaroxaban by Revenue
3.2.1 Global Rivaroxaban Revenue by Manufacturers (2015-2020)
3.2.2 Global Rivaroxaban Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Rivaroxaban Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rivaroxaban as of 2019)
3.4 Global Rivaroxaban Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Rivaroxaban Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Rivaroxaban Market
3.7 Key Manufacturers Rivaroxaban Product Offered
3.8 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Rivaroxaban Historic Market Review by Type (2015-2020)
4.1.2 Global Rivaroxaban Sales Market Share by Type (2015-2020)
4.1.3 Global Rivaroxaban Revenue Market Share by Type (2015-2020)
4.1.4 Rivaroxaban Price by Type (2015-2020)
4.1 Global Rivaroxaban Market Estimates and Forecasts by Type (2021-2026)
4.2.2 Global Rivaroxaban Sales Forecast by Type (2021-2026)
4.2.3 Global Rivaroxaban Revenue Forecast by Type (2021-2026)
4.2.4 Rivaroxaban Price Forecast by Type (2021-2026)

5 Global Rivaroxaban Market Size by Application
5.1 Global Rivaroxaban Historic Market Review by Application (2015-2020)
5.1.2 Global Rivaroxaban Sales Market Share by Application (2015-2020)
5.1.3 Global Rivaroxaban Revenue Market Share by Application (2015-2020)
5.1.4 Rivaroxaban Price by Application (2015-2020)
5.2 Global Rivaroxaban Market Estimates and Forecasts by Application (2021-2026)
5.2.2 Global Rivaroxaban Sales Forecast by Application (2021-2026)
5.2.3 Global Rivaroxaban Revenue Forecast by Application (2021-2026)
5.2.4 Rivaroxaban Price Forecast by Application (2021-2026)

6 North America
6.1 North America Rivaroxaban Breakdown Data by Company
6.2 North America Rivaroxaban Breakdown Data by Type
6.3 North America Rivaroxaban Breakdown Data by Application
6.4 North America Rivaroxaban Breakdown Data by Countries
6.4.1 North America Rivaroxaban Sales by Countries
6.4.2 North America Rivaroxaban Revenue by Countries
6.4.3 U.S.
6.4.4 Canada

7 Europe
7.1 Europe Rivaroxaban Breakdown Data by Company
7.2 Europe Rivaroxaban Breakdown Data by Type
7.3 Europe Rivaroxaban Breakdown Data by Application
7.4 Europe Rivaroxaban Breakdown Data by Countries
7.4.1 Europe Rivaroxaban Sales by Countries
7.4.2 Europe Rivaroxaban Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Rivaroxaban Breakdown Data by Company
8.2 Asia Pacific Rivaroxaban Breakdown Data by Type
8.3 Asia Pacific Rivaroxaban Breakdown Data by Application
8.4 Asia Pacific Rivaroxaban Breakdown Data by Regions
8.4.1 Asia Pacific Rivaroxaban Sales by Regions
8.4.2 Asia Pacific Rivaroxaban Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam

9 Latin America
9.1 Latin America Rivaroxaban Breakdown Data by Company
9.2 Latin America Rivaroxaban Breakdown Data by Type
9.3 Latin America Rivaroxaban Breakdown Data by Application
9.4 Latin America Rivaroxaban Breakdown Data by Countries
9.4.1 Latin America Rivaroxaban Sales by Countries
9.4.2 Latin America Rivaroxaban Revenue by Countries
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Rivaroxaban Breakdown Data by Type
10.2 Middle East and Africa Rivaroxaban Breakdown Data by Application
10.3 Middle East and Africa Rivaroxaban Breakdown Data by Countries
10.3.1 Middle East and Africa Rivaroxaban Sales by Countries
10.3.2 Middle East and Africa Rivaroxaban Revenue by Countries
10.3.3 Turkey
10.3.4 Saudi Arabia
10.3.5 U.A.E

11 Company Profiles
11.1 Bayer
11.1.1 Bayer Corporation Information
11.1.2 Bayer Business Overview and Total Revenue (2019 VS 2018)
11.1.3 Bayer Rivaroxaban Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.1.4 Bayer Rivaroxaban Products and Services
11.1.5 Bayer SWOT Analysis
11.1.6 Bayer Recent Developments
11.2 J&J
11.2.1 J&J Corporation Information
11.2.2 J&J Business Overview and Total Revenue (2019 VS 2018)
11.2.3 J&J Rivaroxaban Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.2.4 J&J Rivaroxaban Products and Services
11.2.5 J&J SWOT Analysis
11.2.6 J&J Recent Developments

12 Supply Chain and Sales Channels Analysis
12.1 Supply Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Rivaroxaban Sales Channels
12.2.2 Rivaroxaban Distributors
12.3 Rivaroxaban Customers

13 Estimates and Projections by Regions (2021-2026)
13.1 Global Rivaroxaban Sales Forecast (2021-2026)
13.1.1 Global Rivaroxaban Sales Forecast by Regions (2021-2026)
13.1.2 Global Rivaroxaban Revenue Forecast by Regions (2021-2026)
13.2 North America Market Size Forecast (2021-2026)
13.2.1 North America Rivaroxaban Sales Forecast (2021-2026)
13.2.2 North America Rivaroxaban Revenue Forecast (2021-2026)
13.2.3 North America Rivaroxaban Size Forecast by County (2021-2026)
13.3 Europe Market Size Forecast (2021-2026)
13.3.1 Europe Rivaroxaban Sales Forecast (2021-2026)
13.3.2 Europe Rivaroxaban Revenue Forecast (2021-2026)
13.3.3 Europe Rivaroxaban Size Forecast by County (2021-2026)
13.4 Asia Pacific Market Size Forecast (2021-2026)
13.4.1 Asia Pacific Rivaroxaban Sales Forecast (2021-2026)
13.4.2 Asia Pacific Rivaroxaban Revenue Forecast (2021-2026)
13.4.3 Asia Pacific Rivaroxaban Size Forecast by Region (2021-2026)
13.5 Latin America Market Size Forecast (2021-2026)
13.5.1 Latin America Rivaroxaban Sales Forecast (2021-2026)
13.5.2 Latin America Rivaroxaban Revenue Forecast (2021-2026)
13.5.3 Latin America Rivaroxaban Size Forecast by County (2021-2026)
13.6 Middle East and Africa Market Forecast
13.6.1 Middle East and Africa Rivaroxaban Sales Forecast (2021-2026)
13.6.2 Middle East and Africa Rivaroxaban Revenue Forecast (2021-2026)
13.6.3 Middle East and Africa Rivaroxaban Size Forecast by County (2021-2026)

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Rivaroxaban Key Market Segments
Table 2. Ranking of Global Top Rivaroxaban Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Rivaroxaban Market Size Growth Rate by Type 2021-2026 (M Units) & (Million US$)
Table 4. Major Manufacturers of 2.5 mg
Table 5. Major Manufacturers of 10 mg
Table 6. Major Manufacturers of 15 mg
Table 7. Major Manufacturers of 20 mg
Table 8. Global Rivaroxaban Market Share by Application 2019-2025 (M Units)
Table 9. Global Rivaroxaban Market Size by Regions 2015-2020 (M Units) & (Million US$)
Table 10. Global Rivaroxaban Sales by Regions 2015-2020 (M Units)
Table 11. Global Rivaroxaban Sales Market Share by Regions 2015-2020
Table 12. Global Rivaroxaban Revenue by Regions 2015-2020 (Million US$)
Table 13. Global Rivaroxaban Revenue Market Share by Regions 2015-2020
Table 14. Top Rivaroxaban Regions (Countries) Ranking by Market Size (US$ Million) in 2019
Table 15. Market Top Trends
Table 16. Rivaroxaban Key Drivers: Impact Analysis (2021-2026)
Table 17. Rivaroxaban Key Challenges
Table 18. Main Points Interviewed from Key Rivaroxaban Players: Views for Future
Table 19. Global Rivaroxaban Sales by Manufacturers (2015-2020) (M Units)
Table 20. Global Rivaroxaban Sales Share by Manufacturers (2015-2020)
Table 21. Rivaroxaban Revenue by Manufacturers (2015-2020) (Million US$)
Table 22. Rivaroxaban Revenue Share by Manufacturers (2015-2020)
Table 23. Global Rivaroxaban Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rivaroxaban as of 2019)
Table 25. Key Manufacturers Rivaroxaban Average Selling Price (ASP) (2015-2020) (USD/Unit)
Table 26. Key Manufacturers Rivaroxaban Plants/Factories Distribution
Table 27. Key Manufacturers Rivaroxaban Area Served
Table 28. Date of Key Manufacturers Enter into Rivaroxaban Market
Table 29. Key Manufacturers Rivaroxaban Product Type
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global 2.5 mg Sales and Revenue (2015-2020) (M Units) & (Million US$)
Table 32. Global 10 mg Sales and Revenue (2015-2020) (M Units) & (Million US$)
Table 33. Global 15 mg Sales ana Revenue (2015-2020) (M Units) & (Million US$)
Table 34. Global 20 mg Sales ana Revenue (2015-2020) (M Units) & (Million US$)
Table 35. Global Rivaroxaban Sales (M Units) by Type (2015-2020)
Table 36. Global Rivaroxaban Sales Share by Type (2015-2020)
Table 37. Global Rivaroxaban Revenue (US$ Million) Market Share by Type (2015-2020)
Table 38. Global Rivaroxaban Price (M Units) by Type (2015-2020)
Table 39. Global Rivaroxaban Sales (M Units) by Type (2021-2026)
Table 40. Global Rivaroxaban Sales Share by Type (2021-2026)
Table 41. Global Rivaroxaban Revenue (US$ Million) Market Share by Type (2021-2026)
Table 42. Global Rivaroxaban Revenue Share by Type (2021-2026)
Table 43. Global Rivaroxaban Price (M Units) by Type (2021-2026)
Table 44. Global Rivaroxaban Sales (M Units) by Application (2015-2020)
Table 45. Global Rivaroxaban Sales Share by Application (2015-2020)
Table 46. Global Rivaroxaban Revenue (US$ Million) Market Share by Application (2015-2020)
Table 47. Global Rivaroxaban Price by Application 2015-2020 (USD/Unit)
Table 48. Global Rivaroxaban Sales by Application (2015-2020) (M Units)
Table 49. Global Rivaroxaban Sales Share by Application (2015-2020)
Table 50. Global Rivaroxaban Revenue (US$ Million) Market Share by Application (2021-2026)
Table 51. Global Rivaroxaban Revenue Share by Application (2021-2026)
Table 52. Global Rivaroxaban Price (M Units) by Application (2021-2026)
Table 53. North America Rivaroxaban Sales by Company (2015-2020) (M Units)
Table 54. North America Rivaroxaban Sales Market Share by Company (2015-2020)
Table 55. North America Rivaroxaban Sales by Type (2015-2020) (M Units)
Table 56. North America Rivaroxaban Sales Market Share by Type (2015-2020)
Table 57. North America Rivaroxaban Sales by Application (2015-2020) (M Units)
Table 58. North America Rivaroxaban Sales Market Share by Application (2015-2020)
Table 59. North America Rivaroxaban Sales by Countries (2015-2020) (M Units)
Table 60. North America Rivaroxaban Sales Market Share by Countries (2015-2020)
Table 61. North America Rivaroxaban Revenue by Countries (2015-2020) (Million US$)
Table 62. North America Rivaroxaban Revenue Market Share by Countries (2015-2020)
Table 63. Europe Rivaroxaban Sales by Company (2015-2020) (M Units)
Table 64. Europe Rivaroxaban Sales Market Share by Company (2015-2020)
Table 65. Europe Rivaroxaban Sales by Type (2015-2020) (M Units)
Table 66. Europe Rivaroxaban Sales Market Share by Type (2015-2020)
Table 67. Europe Rivaroxaban Sales by Application (2015-2020) (M Units)
Table 68. Europe Rivaroxaban Sales Market Share by Application (2015-2020)
Table 69. Europe Rivaroxaban Sales by Countries (2015-2020) (M Units)
Table 70. Europe Rivaroxaban Sales Market Share by Countries (2015-2020)
Table 71. Europe Rivaroxaban Revenue by Countries (2015-2020) (Million US$)
Table 72. Europe Rivaroxaban Revenue Market Share by Countries (2015-2020)
Table 73. Asia Pacific Rivaroxaban Sales by Regions (2015-2020) (M Units)
Table 74. Asia Pacific Rivaroxaban Sales Market Share by Regions (2015-2020)
Table 75. Asia Pacific Rivaroxaban Sales by Type (2015-2020) (M Units)
Table 76. Asia Pacific Rivaroxaban Sales Market Share by Type (2015-2020)
Table 77. Asia Pacific Rivaroxaban Sales by Application (2015-2020) (M Units)
Table 78. Asia Pacific Rivaroxaban Sales Market Share by Application (2015-2020)
Table 79. Asia Pacific Rivaroxaban Sales by Countries (2015-2020) (M Units)
Table 80. Asia Pacific Rivaroxaban Sales Market Share by Regions (2015-2020)
Table 81. Asia Pacific Rivaroxaban Revenue by Regions (2015-2020) (Million US$)
Table 82. Asia Pacific Rivaroxaban Revenue Market Share by Regions (2015-2020)
Table 83. Latin America Rivaroxaban Sales by Company (2015-2020) (M Units)
Table 84. Latin America Rivaroxaban Sales Market Share by Company (2015-2020)
Table 85. Latin America Rivaroxaban Sales by Type (2015-2020) (M Units)
Table 86. Latin America Rivaroxaban Sales Market Share by Type (2015-2020)
Table 87. Latin America Rivaroxaban Sales by Application (2015-2020) (M Units)
Table 88. Latin America Rivaroxaban Sales Market Share by Application (2015-2020)
Table 89. Latin America Rivaroxaban Sales by Countries (2015-2020) (M Units)
Table 90. Latin America Rivaroxaban Sales Market Share by Countries (2015-2020)
Table 91. Latin America Rivaroxaban Revenue by Countries (2015-2020) (Million US$)
Table 92. Latin America Rivaroxaban Revenue Market Share by Countries (2015-2020)
Table 93. Middle East and Africa Rivaroxaban Sales by Type (2015-2020) (M Units)
Table 94. Middle East and Africa Rivaroxaban Sales Market Share by Type (2015-2020)
Table 95. Middle East and Africa Rivaroxaban Sales by Application (2015-2020) (M Units)
Table 96. Middle East and Africa Rivaroxaban Sales Market Share by Application (2015-2020)
Table 97. Middle East and Africa Rivaroxaban Sales by Countries (2015-2020) (M Units)
Table 98. Middle East and Africa Rivaroxaban Sales Market Share by Countries (2015-2020)
Table 99. Middle East and Africa Rivaroxaban Revenue by Countries (2015-2020) (Million US$)
Table 100. Middle East and Africa Rivaroxaban Revenue Market Share by Countries (2015-2020)
Table 101. Bayer Company Details
Table 102. Bayer Description and Business Overview
Table 103. Bayer Rivaroxaban Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 104. Bayer Rivaroxaban Sales Growth Rate (2015-2020)
Table 105. Bayer Rivaroxaban Sales Market Share in Global Market
Table 106. Bayer Recent Development
Table 107. J&J Company Details
Table 108. J&J Description and Business Overview
Table 109. J&J Rivaroxaban Sales (M Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 110. J&J Rivaroxaban Sales Growth Rate (2015-2020)
Table 111. J&J Rivaroxaban Sales Market Share in Global Market
Table 112. J&J Recent Development
Table 113. Rivaroxaban Distributors List
Table 114. Rivaroxaban Customers List
Table 115. Global Rivaroxaban Sales Forecast 2021-2026 (M Units) & (Million US$)
Table 116. Global Rivaroxaban Sales Forecast by Type 2021-2026 (M Units)
Table 117. Global Rivaroxaban Sales Forecast by Application 2021-2026 (M Units)
Table 118. Global Rivaroxaban Sales Forecast by Regions 2021-2026 (M Units)
Table 119. Global Rivaroxaban Revenue Forecast by Regions 2021-2026 (Million US$)
Table 120. North America Rivaroxaban Sales Forecast by Countries 2021-2026 (M Units)
Table 121. North America Rivaroxaban Revenue Forecast by Countries 2021-2026
Table 122. Europe Rivaroxaban Sales Forecast by Countries 2021-2026 (M Units)
Table 123. Europe Rivaroxaban Revenue Market Share Forecast by Countries 2021-2026
Table 124. Asia Pacific Rivaroxaban Sales Forecast by Regions 2021-2026 (M Units)
Table 125. Asia Pacific Rivaroxaban Revenue Forecast by Regions 2021-2026 (Million US$)
Table 126. Latin America Rivaroxaban Sales Forecast by Countries 2021-2026 (M Units)
Table 127. Latin America Rivaroxaban Revenue Forecast by Countries 2021-2026 (Million US$)
Table 128. Middle East and Africa Rivaroxaban Sales Forecast by Regions 2021-2026 (M Units)
Table 129. Middle East and Africa Rivaroxaban Revenue Forecast by Regions 2021-2026 (Million US$)
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. Rivaroxaban Product Picture
Figure 2. Global Rivaroxaban Sales Market Shar by Type 2015-2026
Figure 3. 2.5 mg Figures
Figure 4. 10 mg Figures
Figure 5. 15 mg Figures
Figure 6. 20 mg Figures
Figure 7. Global Rivaroxaban Sales Market Share by Application in 2019 & 2026
Figure 8. Acute Coronary Syndrome (ACS) Use Case
Figure 9. Venous Thromboembolism (VTE) Use Case
Figure 10. Rivaroxaban Report Years Considered
Figure 11. Global Rivaroxaban Market Size 2015-2026 (Million US$)
Figure 12. Global Rivaroxaban Sales 2015-2020 (M Units)
Figure 13. Global Rivaroxaban Market Size Market Share by Regions 2015-2020
Figure 14. Global Rivaroxaban Sales Market Share by Regions in 2019
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Rivaroxaban Sales Share by Manufacturers in 2019
Figure 17. The 5 and 10 Largest Manufacturers in the World: Market Share by Rivaroxaban Sales in 2019
Figure 18. Rivaroxaban Value Share by Manufacturers in 2019
Figure 19. Rivaroxaban Revenue Share by Manufacturers In 2019
Figure 20. Rivaroxaban Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Rivaroxaban Revenue Share by Type (2015-2020)
Figure 22. Global Rivaroxaban Revenue Growth Rate by Type in 2015 & 2019
Figure 23. Global Rivaroxaban Market Share by Price Range (2015-2020)
Figure 24. Global Rivaroxaban Revenue Share by Application (2015-2020)
Figure 25. Global Rivaroxaban Revenue Growth Rate by Application in 2015 & 2019
Figure 26. North America Rivaroxaban Revenue Growth Rate 2015-2020 (Million US$)
Figure 27. U.S. Rivaroxaban Sales Growth Rate (2015-2020) (M Units)
Figure 28. Canada Rivaroxaban Sales Growth Rate (2015-2020) (M Units)
Figure 29. Europe Rivaroxaban Revenue Growth Rate 2015-2020 (Million US$)
Figure 30. Germany Rivaroxaban Sales Growth Rate (2015-2020) (M Units)
Figure 31. France Rivaroxaban Sales Growth Rate (2015-2020) (M Units)
Figure 32. U.K. Rivaroxaban Sales Growth Rate (2015-2020) (M Units)
Figure 33. Italy Rivaroxaban Sales Growth Rate (2015-2020) (M Units)
Figure 34. Russia Rivaroxaban Sales Growth Rate (2015-2020) (M Units)
Figure 35. Asia Pacific Rivaroxaban Revenue Growth Rate 2015-2020 (Million US$)
Figure 36. China Rivaroxaban Sales Growth Rate (2015-2020) (M Units)
Figure 37. Japan Rivaroxaban Sales Growth Rate (2015-2020) (M Units)
Figure 38. South Korea Rivaroxaban Sales Growth Rate (2015-2020) (M Units)
Figure 39. India Rivaroxaban Sales Growth Rate (2015-2020) (M Units)
Figure 40. Australia Rivaroxaban Sales Growth Rate (2015-2020) (M Units)
Figure 41. Taiwan Rivaroxaban Sales Growth Rate (2015-2020) (M Units)
Figure 42. Indonesia Rivaroxaban Sales Growth Rate (2015-2020) (M Units)
Figure 43. Thailand Rivaroxaban Sales Growth Rate (2015-2020) (M Units)
Figure 44. Malaysia Rivaroxaban Sales Growth Rate (2015-2020) (M Units)
Figure 45. Philippines Rivaroxaban Sales Growth Rate (2015-2020) (M Units)
Figure 46. Vietnam Rivaroxaban Sales Growth Rate (2015-2020) (M Units)
Figure 47. Latin America Rivaroxaban Revenue Growth Rate 2015-2020 (Million US$)
Figure 48. Mexico Rivaroxaban Sales Growth Rate (2015-2020) (M Units)
Figure 49. Brazil Rivaroxaban Sales Growth Rate (2015-2020) (M Units)
Figure 50. Argentina Rivaroxaban Sales Growth Rate (2015-2020) (M Units)
Figure 51. Middle East and Africa Rivaroxaban Revenue Growth Rate 2015-2020 (Million US$)
Figure 52. Turkey Rivaroxaban Sales Growth Rate (2015-2020) (M Units)
Figure 53. Saudi Arabia Rivaroxaban Sales Growth Rate (2015-2020) (M Units)
Figure 54. U.A.E Rivaroxaban Sales Growth Rate (2015-2020) (M Units)
Figure 55. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. J&J Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Rivaroxaban Value Chain
Figure 58. Channels of Distribution
Figure 59. Distributors Profiles
Figure 60. North America Rivaroxaban Sales Growth Rate Forecast (2021-2026) (M Units)
Figure 61. North America Rivaroxaban Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 62. Europe Rivaroxaban Sales Growth Rate Forecast (2021-2026) (M Units)
Figure 63. Europe Rivaroxaban Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 64. Asia Pacific Rivaroxaban Sales Growth Rate Forecast (2021-2026) (M Units)
Figure 65. Asia Pacific Rivaroxaban Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 66. Latin America Rivaroxaban Sales Growth Rate Forecast (2021-2026) (M Units)
Figure 67. Latin America Rivaroxaban Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 68. Middle East and Africa Rivaroxaban Sales Growth Rate Forecast (2021-2026) (M Units)
Figure 69. Middle East and Africa Rivaroxaban Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed


【掲載企業】

Bayer、J&J

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ リバーロキサバンの世界市場2020-2026:2.5 mg、10 mg、15 mg、20 mg(Global Rivaroxaban Industry Research Report, Growth Trends and Competitive Analysis 2020-2026)]についてメールでお問い合わせはこちらでお願いします。